Lumos Pharma | NLNK - Market Capitalization


Lumos Pharma reported $21.8M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Alterity Therapeutics Limited AUD 40M 16M May/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Celldex Therapeutics USD 2.17B 361M May/2026
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Incyte USD 21.73B 3B May/2026
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Pfizer USD 148.08B 6.51B May/2026
Prothena USD 514M 11M Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025